Despite overall mutational frequencies of the IL33 gene in all tumors examined remain low (0.072–1.391%), some mutations found at the specific motif in each domain of IL-33 may result in aberrant IL-33 function associated with tumor regression or progression. Here, IL33 is linked to neoplasm.